Because an increased rate of resistance to PON was reported in either preclinical or clinical settings, with autophagy being the primarily responsible mechanism, Corallo et al. [14] investigated its cytoprotective role in NB cells during treatment with PON. This evidence concerns the gene PON1 and neuroblastoma.